Celiac disease

Current Opinion in Gastroenterology

Volumn 15, Issue 2, 1999, Pages 120-124

  Parnell, Nick ^a   Ciclitira, Paul J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; ENDOMYSIUM ANTIBODY; GLIADIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

CELIAC DISEASE; DERMATITIS HERPETIFORMIS; FOOD SAFETY; HUMAN; IMMUNOLOGY; MASS SCREENING; MOLECULAR BIOLOGY; OAT; PATHOGENESIS; PROTEIN BINDING; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE LEVEL;

EID: 0033009262     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199903000-00006     Document Type: Review

References (35)

1. 1 Collin P, Reunala T, Rasmussen M, et al.: High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol 1997, 32:1129-1133. Confirms that the majority of celiac patients do not have "classic" symptoms and will remain undiagnosed unless awareness is heightened and at-risk groups screened.
2. 2 Corazza GR, Andreani ML, Biagi F, et al.: The smaller size of the "coeliac iceberg" in adults. Scand J Gastroenterol 1997, 32:917-919.
3. 3 Catassi C, Rätsch IM, Fabiani E, et al.: Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994, 343:200-203.
4. 4 Not T, Horvath K, Hill ID, et al.: Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998, 33:494-498.
5. 5 Greco L, Corazza G, Babron M-C, et al.: Genome search in celiac disease. Am J Hum Genet 1998, 62:669-675. Large linkage study taking the search for additional genetic risk factors further.
6. 6 Zhong F, McCombs C, Olson JM, et al.: An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat Genet 1996, 14:329-333.
7. 7 Cronin CC, Feighery A, Ferriss JB, Liddy C, Shanahan F, Feighery C: High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol 1997, 92:2210-2212.
8. 8 Sjöberg K, Eriksson KF, Bredberg A, Wassmuth R, Eriksson S: Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med 1998, 243:133-140.
9. 9 Volta U, De Franceschi L, Lari F, Molinaro N, Zoli M, Bianchi FB: Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet 1998, 352:26-29. Demonstrates a high prevalence of celiac disease in patients with asymptomatic raised hepatic transaminases of unknown cause, and reveals the gluten-dependent nature of the liver injury.
10. 10 Logan RFA, Ferguson A, Finlayson NDC, et al.: Primary biliary cirrhosis and coeliac disease: an association? Lancet 1978, 1230-233.
11. 11 Kingham JGC, Parker DR: The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998, 42:120-122.
12. 12 Bardella MT, Quatrini M, Zuin M, et al.: Screening patients with celiac disease for primary biliary cirrhosis and vice versa. Am J Gastroenterol 1997, 92:1524-1526.
13. 13 Sjöberg K, Lindgren S, Eriksson S: Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Scand J Gastroenterol 1997, 32:1162-1167.
14. 14 Velluzzi F, Caradonna A, Boy MF, et al.: Thyroid and celiac disease: clinical, serological, and echographic study. Am J Gastroenterol 1998, 93:976-979.
15. 15 Cronin CC, Jackson LM, Feighery C, et al.: Coeliac disease and epilepsy. Q J Med 1998, 91:303-308.
16. 16 Mora S, Barera G, Ricotti A, Weber G, Bianchi C, Chiumello G: Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease. Am J Clin Nutr 1998, 67:477-481.
17. 17 Stevens FM, Kearns MC, McCarthy CF: Abnormal pancreolauryl tests in coeliac disease: lack of correlation with the degree of intestinal mucosal damage. J Clin Pathol 1997, 50:1001-1004.
18. 18 Janatuinen EK, Pikkarainen PH, Kemppainen TA, et al.: A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995, 333:1033-1037.
19. 19 Srinivasan U, Leonard N, Jones E, et al..: Absence of oats toxicity in adult coeliac disease. Br Med J 1996, 313:1300-1301.
20. 20 Hardman CM, Garioch JJ, Leonard JN, et al.: Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997, 337:1884-1887. Further evidence for the possible safety of oats in gluten sensitive disease.
21. 21 Parnell NDJ, Ellis HJ, Ciclitira P: Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1998, 338:1470.
22. 22 Holmes GKT, Prior P, Lane MR, Pope D, Allan RN: Malignancy in coeliac disease: effect of a gluten free diet. Gut 1989, 30:333-338.
23. 23 Kingham JG, Ramanaden D, Dawson A: Metachronous small-bowel adenocarcinoma in coeliac disease: gluten-free diet is not protective. Scand J Gastroenterol 1998, 33:218-222. Suggests that this rare association with celiac disease is not dependent on the enteropathy as seems to be the case with lymphoma.
24. 24 Cellier C, Patey N, Mauvieux L, et al.: Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998,114:471-481. Molecular insight into a difficult area; suggests that refractory celiac disease can be distinguished from gluten-responsive disease by Intraepithelial lymphocyte phenotype,
25. 25 Dieterich W, Ehnis T, Bauer M, et al.: Identification of tissue transglutamirase as the autoantlgen of celiac disease. Nat Med 1997, 3:797-801.
26. 26 Molberg Ø, Mcadam SN, Körner R, et al.: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998, 4:713-717. Seminal paper describing a role for tTG in celiac disease pathogenesis.
27. 27 Sjöström H, Lundin KEA, Molberg Ø, et at.: Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 1998, 48:111-115.
28. 28 van de Wal Y, Kooy YMC, van Veelen PA, et al.: Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A 1998, 95:10050-10054. Advances the search for toxic gluten epitopes.
29. 29 Sturgess R, Day P, Ellis HJ, Lundin KEA, Gjertsen HA, Kontakou M, Ciclitira PJ: Wheat peptide challenge in coeliac disease. Lancet 1994, 343:758-761.
30. 30 van de Wal Y, Kooy Y, van Veelen P, et al,: Cutting edge: selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998, 161:1585-1588. Confirmation of a pathogenic role for tTG.
31. 31 Shidrawi RG, Parnell NDJ, Ciclitira PJ, Travers P, Evan G, Rosen-Bronson S: Binding of gluten-derived peptides to the HLA-DQ2 (a1*0501, b1*0201) molecule, assessed in a cellular assay. Clin Exp Immunol 1998, 111:158-165.
32. 32 Nilsen EM, Jahnsen FL, Lundin KEA, et al.: Gluten induces an intestinal cytokine response strongly dominated by Interferon gamma in patients with celiac disease. Gastroenterology 1998, 115:551-563.
33. 33 Troncone R, Gianfrani C, Mazzarella G, et al.: Majority of gliadin specific T-call clones from celiac small intestinal mucosa produce interferon-g and interleukin-4. Dig Dis Sci 1998, 43:156-161.
34. 34 Maiuri L, Auricchio S, Coletta S, et al.: Blockage of T-cell costimulation inhibits T-cell action in celiac disease. Gastroenteroiogy 1998, 115:564-572. Suggests a less central role for intestinal T cells than conventionally thought.
35. 35 Maiuri L, Picarelli A, Boirivant M, et al.: Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996, 110:1368-1378.